Industry Research Reports

Home > Reports > Chemical & Material > Risperidone API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Risperidone API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Chemical & Material

Published Date: 2025-01-16

Pages: 164 Pages

Report ld: 3565580

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Risperidone API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Risperidone(CAS：106266-06-2) is an atypical antipsychotic used to treat schizophrenia and bipolar disorder.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Risperidone API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Risperidone API by region & country, by Type, and by Application.

The Risperidone API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperidone API.

MARKET SEGMENTATION

By Company

Interquim SA
Inke S.A
Jai Radhe Sales
Dr. Reddy's Laboratories
Mylan
Teva
RPG Life Sciences Ltd.
Wuxi Jida Pharmaceutical Co., Ltd.
Venkata Narayana Active Ingredients
Torrent Pharmaceuticals Limited
Zhejiang Huahai Pharmaceutical
Icrom
Jubilant Generics
Jeil Pharmaceutical Co., Ltd
Aurobindo Pharma Limited
Enaltec Labs Private Limited
Anugraha Chemicals
Otto Brandes
Aurore Life Sciences
Guangzhou Tosun Pharmaceutical
Jiangsu Nhwa Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Oral Solution
Capsules
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Risperidone API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Risperidone API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Risperidone API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Risperidone API Product Introduction

1.2 Global Risperidone API Market Size Forecast

1.2.1 Global Risperidone API Sales Value (2020-2031)

1.2.2 Global Risperidone API Sales Volume (2020-2031)

1.2.3 Global Risperidone API Sales Price (2020-2031)

1.3 Risperidone API Market Trends & Drivers

1.3.1 Risperidone API Industry Trends

1.3.2 Risperidone API Market Drivers & Opportunity

1.3.3 Risperidone API Market Challenges

1.3.4 Risperidone API Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Risperidone API Players Revenue Ranking (2024)

2.2 Global Risperidone API Revenue by Company (2020-2025)

2.3 Global Risperidone API Players Sales Volume Ranking (2024)

2.4 Global Risperidone API Sales Volume by Company Players (2020-2025)

2.5 Global Risperidone API Average Price by Company (2020-2025)

2.6 Key Manufacturers Risperidone API Manufacturing Base and Headquarters

2.7 Key Manufacturers Risperidone API Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Risperidone API

2.9 Risperidone API Market Competitive Analysis

2.9.1 Risperidone API Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Risperidone API Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone API as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Above 98 %

3.1.2 Above 99 %

3.2 Global Risperidone API Sales Value by Type

3.2.1 Global Risperidone API Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Risperidone API Sales Value, by Type (2020-2031)

3.2.3 Global Risperidone API Sales Value, by Type (%) (2020-2031)

3.3 Global Risperidone API Sales Volume by Type

3.3.1 Global Risperidone API Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Risperidone API Sales Volume, by Type (2020-2031)

3.3.3 Global Risperidone API Sales Volume, by Type (%) (2020-2031)

3.4 Global Risperidone API Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Oral Solution

4.1.3 Capsules

4.1.4 Others

4.2 Global Risperidone API Sales Value by Application

4.2.1 Global Risperidone API Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Risperidone API Sales Value, by Application (2020-2031)

4.2.3 Global Risperidone API Sales Value, by Application (%) (2020-2031)

4.3 Global Risperidone API Sales Volume by Application

4.3.1 Global Risperidone API Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Risperidone API Sales Volume, by Application (2020-2031)

4.3.3 Global Risperidone API Sales Volume, by Application (%) (2020-2031)

4.4 Global Risperidone API Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Risperidone API Sales Value by Region

5.1.1 Global Risperidone API Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Risperidone API Sales Value by Region (2020-2025)

5.1.3 Global Risperidone API Sales Value by Region (2026-2031)

5.1.4 Global Risperidone API Sales Value by Region (%), (2020-2031)

5.2 Global Risperidone API Sales Volume by Region

5.2.1 Global Risperidone API Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Risperidone API Sales Volume by Region (2020-2025)

5.2.3 Global Risperidone API Sales Volume by Region (2026-2031)

5.2.4 Global Risperidone API Sales Volume by Region (%), (2020-2031)

5.3 Global Risperidone API Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Risperidone API Sales Value, 2020-2031

5.4.2 North America Risperidone API Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Risperidone API Sales Value, 2020-2031

5.5.2 Europe Risperidone API Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Risperidone API Sales Value, 2020-2031

5.6.2 Asia Pacific Risperidone API Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Risperidone API Sales Value, 2020-2031

5.7.2 South America Risperidone API Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Risperidone API Sales Value, 2020-2031

5.8.2 Middle East & Africa Risperidone API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Risperidone API Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Risperidone API Sales Value

6.2.1 Key Countries/Regions Risperidone API Sales Value, 2020-2031

6.2.2 Key Countries/Regions Risperidone API Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Risperidone API Sales Value, 2020-2031

6.3.2 United States Risperidone API Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Risperidone API Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Risperidone API Sales Value, 2020-2031

6.4.2 Europe Risperidone API Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Risperidone API Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Risperidone API Sales Value, 2020-2031

6.5.2 China Risperidone API Sales Value by Type (%), 2024 VS 2031

6.5.3 China Risperidone API Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Risperidone API Sales Value, 2020-2031

6.6.2 Japan Risperidone API Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Risperidone API Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Risperidone API Sales Value, 2020-2031

6.7.2 South Korea Risperidone API Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Risperidone API Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Risperidone API Sales Value, 2020-2031

6.8.2 Southeast Asia Risperidone API Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Risperidone API Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Risperidone API Sales Value, 2020-2031

6.9.2 India Risperidone API Sales Value by Type (%), 2024 VS 2031

6.9.3 India Risperidone API Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Interquim SA

7.1.1 Interquim SA Company Information

7.1.2 Interquim SA Introduction and Business Overview

7.1.3 Interquim SA Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Interquim SA Risperidone API Product Offerings

7.1.5 Interquim SA Recent Development

7.2 Inke S.A

7.2.1 Inke S.A Company Information

7.2.2 Inke S.A Introduction and Business Overview

7.2.3 Inke S.A Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Inke S.A Risperidone API Product Offerings

7.2.5 Inke S.A Recent Development

7.3 Jai Radhe Sales

7.3.1 Jai Radhe Sales Company Information

7.3.2 Jai Radhe Sales Introduction and Business Overview

7.3.3 Jai Radhe Sales Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Jai Radhe Sales Risperidone API Product Offerings

7.3.5 Jai Radhe Sales Recent Development

7.4 Dr. Reddy's Laboratories

7.4.1 Dr. Reddy's Laboratories Company Information

7.4.2 Dr. Reddy's Laboratories Introduction and Business Overview

7.4.3 Dr. Reddy's Laboratories Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Dr. Reddy's Laboratories Risperidone API Product Offerings

7.4.5 Dr. Reddy's Laboratories Recent Development

7.5 Mylan

7.5.1 Mylan Company Information

7.5.2 Mylan Introduction and Business Overview

7.5.3 Mylan Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Mylan Risperidone API Product Offerings

7.5.5 Mylan Recent Development

7.6 Teva

7.6.1 Teva Company Information

7.6.2 Teva Introduction and Business Overview

7.6.3 Teva Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Teva Risperidone API Product Offerings

7.6.5 Teva Recent Development

7.7 RPG Life Sciences Ltd.

7.7.1 RPG Life Sciences Ltd. Company Information

7.7.2 RPG Life Sciences Ltd. Introduction and Business Overview

7.7.3 RPG Life Sciences Ltd. Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 RPG Life Sciences Ltd. Risperidone API Product Offerings

7.7.5 RPG Life Sciences Ltd. Recent Development

7.8 Wuxi Jida Pharmaceutical Co., Ltd.

7.8.1 Wuxi Jida Pharmaceutical Co., Ltd. Company Information

7.8.2 Wuxi Jida Pharmaceutical Co., Ltd. Introduction and Business Overview

7.8.3 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Product Offerings

7.8.5 Wuxi Jida Pharmaceutical Co., Ltd. Recent Development

7.9 Venkata Narayana Active Ingredients

7.9.1 Venkata Narayana Active Ingredients Company Information

7.9.2 Venkata Narayana Active Ingredients Introduction and Business Overview

7.9.3 Venkata Narayana Active Ingredients Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Venkata Narayana Active Ingredients Risperidone API Product Offerings

7.9.5 Venkata Narayana Active Ingredients Recent Development

7.10 Torrent Pharmaceuticals Limited

7.10.1 Torrent Pharmaceuticals Limited Company Information

7.10.2 Torrent Pharmaceuticals Limited Introduction and Business Overview

7.10.3 Torrent Pharmaceuticals Limited Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Torrent Pharmaceuticals Limited Risperidone API Product Offerings

7.10.5 Torrent Pharmaceuticals Limited Recent Development

7.11 Zhejiang Huahai Pharmaceutical

7.11.1 Zhejiang Huahai Pharmaceutical Company Information

7.11.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview

7.11.3 Zhejiang Huahai Pharmaceutical Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Zhejiang Huahai Pharmaceutical Risperidone API Product Offerings

7.11.5 Zhejiang Huahai Pharmaceutical Recent Development

7.12 Icrom

7.12.1 Icrom Company Information

7.12.2 Icrom Introduction and Business Overview

7.12.3 Icrom Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Icrom Risperidone API Product Offerings

7.12.5 Icrom Recent Development

7.13 Jubilant Generics

7.13.1 Jubilant Generics Company Information

7.13.2 Jubilant Generics Introduction and Business Overview

7.13.3 Jubilant Generics Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Jubilant Generics Risperidone API Product Offerings

7.13.5 Jubilant Generics Recent Development

7.14 Jeil Pharmaceutical Co., Ltd

7.14.1 Jeil Pharmaceutical Co., Ltd Company Information

7.14.2 Jeil Pharmaceutical Co., Ltd Introduction and Business Overview

7.14.3 Jeil Pharmaceutical Co., Ltd Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Jeil Pharmaceutical Co., Ltd Risperidone API Product Offerings

7.14.5 Jeil Pharmaceutical Co., Ltd Recent Development

7.15 Aurobindo Pharma Limited

7.15.1 Aurobindo Pharma Limited Company Information

7.15.2 Aurobindo Pharma Limited Introduction and Business Overview

7.15.3 Aurobindo Pharma Limited Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Aurobindo Pharma Limited Risperidone API Product Offerings

7.15.5 Aurobindo Pharma Limited Recent Development

7.16 Enaltec Labs Private Limited

7.16.1 Enaltec Labs Private Limited Company Information

7.16.2 Enaltec Labs Private Limited Introduction and Business Overview

7.16.3 Enaltec Labs Private Limited Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Enaltec Labs Private Limited Risperidone API Product Offerings

7.16.5 Enaltec Labs Private Limited Recent Development

7.17 Anugraha Chemicals

7.17.1 Anugraha Chemicals Company Information

7.17.2 Anugraha Chemicals Introduction and Business Overview

7.17.3 Anugraha Chemicals Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Anugraha Chemicals Risperidone API Product Offerings

7.17.5 Anugraha Chemicals Recent Development

7.18 Otto Brandes

7.18.1 Otto Brandes Company Information

7.18.2 Otto Brandes Introduction and Business Overview

7.18.3 Otto Brandes Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.18.4 Otto Brandes Risperidone API Product Offerings

7.18.5 Otto Brandes Recent Development

7.19 Aurore Life Sciences

7.19.1 Aurore Life Sciences Company Information

7.19.2 Aurore Life Sciences Introduction and Business Overview

7.19.3 Aurore Life Sciences Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.19.4 Aurore Life Sciences Risperidone API Product Offerings

7.19.5 Aurore Life Sciences Recent Development

7.20 Guangzhou Tosun Pharmaceutical

7.20.1 Guangzhou Tosun Pharmaceutical Company Information

7.20.2 Guangzhou Tosun Pharmaceutical Introduction and Business Overview

7.20.3 Guangzhou Tosun Pharmaceutical Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.20.4 Guangzhou Tosun Pharmaceutical Risperidone API Product Offerings

7.20.5 Guangzhou Tosun Pharmaceutical Recent Development

7.21 Jiangsu Nhwa Pharmaceutical

7.21.1 Jiangsu Nhwa Pharmaceutical Company Information

7.21.2 Jiangsu Nhwa Pharmaceutical Introduction and Business Overview

7.21.3 Jiangsu Nhwa Pharmaceutical Risperidone API Sales, Revenue, Price and Gross Margin (2020-2025)

7.21.4 Jiangsu Nhwa Pharmaceutical Risperidone API Product Offerings

7.21.5 Jiangsu Nhwa Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Risperidone API Industrial Chain

8.2 Risperidone API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Risperidone API Sales Model

8.5.2 Sales Channel

8.5.3 Risperidone API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Risperidone API Market Trends

Table 2. Risperidone API Market Drivers & Opportunity

Table 3. Risperidone API Market Challenges

Table 4. Risperidone API Market Restraints

Table 5. Global Risperidone API Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Risperidone API Revenue Market Share by Company (2020-2025)

Table 7. Global Risperidone API Sales Volume by Company (2020-2025) & (Kg)

Table 8. Global Risperidone API Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Risperidone API Price by Company (2020-2025) & (US$/Kg)

Table 10. Key Manufacturers Risperidone API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Risperidone API Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Risperidone API

Table 13. Global Risperidone API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risperidone API as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Risperidone API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Risperidone API Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Risperidone API Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Risperidone API Sales Market Share in Value by Type (2020-2025)

Table 20. Global Risperidone API Sales Market Share in Value by Type (2026-2031)

Table 21. Global Risperidone API Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)

Table 22. Global Risperidone API Sales Volume by Type (2020-2025) & (Kg)

Table 23. Global Risperidone API Sales Volume by Type (2026-2031) & (Kg)

Table 24. Global Risperidone API Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Risperidone API Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Risperidone API Price by Type (2020-2025) & (US$/Kg)

Table 27. Global Risperidone API Price by Type (2026-2031) & (US$/Kg)

Table 28. Global Risperidone API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Risperidone API Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Risperidone API Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Risperidone API Sales Market Share in Value by Application (2020-2025)

Table 32. Global Risperidone API Sales Market Share in Value by Application (2026-2031)

Table 33. Global Risperidone API Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)

Table 34. Global Risperidone API Sales Volume by Application (2020-2025) & (Kg)

Table 35. Global Risperidone API Sales Volume by Application (2026-2031) & (Kg)

Table 36. Global Risperidone API Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Risperidone API Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Risperidone API Price by Application (2020-2025) & (US$/Kg)

Table 39. Global Risperidone API Price by Application (2026-2031) & (US$/Kg)

Table 40. Global Risperidone API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Risperidone API Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Risperidone API Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Risperidone API Sales Value by Region (2020-2025) & (%)

Table 44. Global Risperidone API Sales Value by Region (2026-2031) & (%)

Table 45. Global Risperidone API Sales Volume by Region (Kg): 2020 VS 2024 VS 2031

Table 46. Global Risperidone API Sales Volume by Region (2020-2025) & (Kg)

Table 47. Global Risperidone API Sales Volume by Region (2026-2031) & (Kg)

Table 48. Global Risperidone API Sales Volume by Region (2020-2025) & (%)

Table 49. Global Risperidone API Sales Volume by Region (2026-2031) & (%)

Table 50. Global Risperidone API Average Price by Region (2020-2025) & (US$/Kg)

Table 51. Global Risperidone API Average Price by Region (2026-2031) & (US$/Kg)

Table 52. Key Countries/Regions Risperidone API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Risperidone API Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Risperidone API Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Risperidone API Sales Volume, (2020-2025) & (Kg)

Table 56. Key Countries/Regions Risperidone API Sales Volume, (2026-2031) & (Kg)

Table 57. Interquim SA Company Information

Table 58. Interquim SA Introduction and Business Overview

Table 59. Interquim SA Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 60. Interquim SA Risperidone API Product Offerings

Table 61. Interquim SA Recent Development

Table 62. Inke S.A Company Information

Table 63. Inke S.A Introduction and Business Overview

Table 64. Inke S.A Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 65. Inke S.A Risperidone API Product Offerings

Table 66. Inke S.A Recent Development

Table 67. Jai Radhe Sales Company Information

Table 68. Jai Radhe Sales Introduction and Business Overview

Table 69. Jai Radhe Sales Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. Jai Radhe Sales Risperidone API Product Offerings

Table 71. Jai Radhe Sales Recent Development

Table 72. Dr. Reddy's Laboratories Company Information

Table 73. Dr. Reddy's Laboratories Introduction and Business Overview

Table 74. Dr. Reddy's Laboratories Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Dr. Reddy's Laboratories Risperidone API Product Offerings

Table 76. Dr. Reddy's Laboratories Recent Development

Table 77. Mylan Company Information

Table 78. Mylan Introduction and Business Overview

Table 79. Mylan Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. Mylan Risperidone API Product Offerings

Table 81. Mylan Recent Development

Table 82. Teva Company Information

Table 83. Teva Introduction and Business Overview

Table 84. Teva Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. Teva Risperidone API Product Offerings

Table 86. Teva Recent Development

Table 87. RPG Life Sciences Ltd. Company Information

Table 88. RPG Life Sciences Ltd. Introduction and Business Overview

Table 89. RPG Life Sciences Ltd. Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. RPG Life Sciences Ltd. Risperidone API Product Offerings

Table 91. RPG Life Sciences Ltd. Recent Development

Table 92. Wuxi Jida Pharmaceutical Co., Ltd. Company Information

Table 93. Wuxi Jida Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 94. Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Product Offerings

Table 96. Wuxi Jida Pharmaceutical Co., Ltd. Recent Development

Table 97. Venkata Narayana Active Ingredients Company Information

Table 98. Venkata Narayana Active Ingredients Introduction and Business Overview

Table 99. Venkata Narayana Active Ingredients Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. Venkata Narayana Active Ingredients Risperidone API Product Offerings

Table 101. Venkata Narayana Active Ingredients Recent Development

Table 102. Torrent Pharmaceuticals Limited Company Information

Table 103. Torrent Pharmaceuticals Limited Introduction and Business Overview

Table 104. Torrent Pharmaceuticals Limited Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. Torrent Pharmaceuticals Limited Risperidone API Product Offerings

Table 106. Torrent Pharmaceuticals Limited Recent Development

Table 107. Zhejiang Huahai Pharmaceutical Company Information

Table 108. Zhejiang Huahai Pharmaceutical Introduction and Business Overview

Table 109. Zhejiang Huahai Pharmaceutical Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 110. Zhejiang Huahai Pharmaceutical Risperidone API Product Offerings

Table 111. Zhejiang Huahai Pharmaceutical Recent Development

Table 112. Icrom Company Information

Table 113. Icrom Introduction and Business Overview

Table 114. Icrom Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 115. Icrom Risperidone API Product Offerings

Table 116. Icrom Recent Development

Table 117. Jubilant Generics Company Information

Table 118. Jubilant Generics Introduction and Business Overview

Table 119. Jubilant Generics Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 120. Jubilant Generics Risperidone API Product Offerings

Table 121. Jubilant Generics Recent Development

Table 122. Jeil Pharmaceutical Co., Ltd Company Information

Table 123. Jeil Pharmaceutical Co., Ltd Introduction and Business Overview

Table 124. Jeil Pharmaceutical Co., Ltd Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 125. Jeil Pharmaceutical Co., Ltd Risperidone API Product Offerings

Table 126. Jeil Pharmaceutical Co., Ltd Recent Development

Table 127. Aurobindo Pharma Limited Company Information

Table 128. Aurobindo Pharma Limited Introduction and Business Overview

Table 129. Aurobindo Pharma Limited Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 130. Aurobindo Pharma Limited Risperidone API Product Offerings

Table 131. Aurobindo Pharma Limited Recent Development

Table 132. Enaltec Labs Private Limited Company Information

Table 133. Enaltec Labs Private Limited Introduction and Business Overview

Table 134. Enaltec Labs Private Limited Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 135. Enaltec Labs Private Limited Risperidone API Product Offerings

Table 136. Enaltec Labs Private Limited Recent Development

Table 137. Anugraha Chemicals Company Information

Table 138. Anugraha Chemicals Introduction and Business Overview

Table 139. Anugraha Chemicals Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 140. Anugraha Chemicals Risperidone API Product Offerings

Table 141. Anugraha Chemicals Recent Development

Table 142. Otto Brandes Company Information

Table 143. Otto Brandes Introduction and Business Overview

Table 144. Otto Brandes Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 145. Otto Brandes Risperidone API Product Offerings

Table 146. Otto Brandes Recent Development

Table 147. Aurore Life Sciences Company Information

Table 148. Aurore Life Sciences Introduction and Business Overview

Table 149. Aurore Life Sciences Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 150. Aurore Life Sciences Risperidone API Product Offerings

Table 151. Aurore Life Sciences Recent Development

Table 152. Guangzhou Tosun Pharmaceutical Company Information

Table 153. Guangzhou Tosun Pharmaceutical Introduction and Business Overview

Table 154. Guangzhou Tosun Pharmaceutical Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 155. Guangzhou Tosun Pharmaceutical Risperidone API Product Offerings

Table 156. Guangzhou Tosun Pharmaceutical Recent Development

Table 157. Jiangsu Nhwa Pharmaceutical Company Information

Table 158. Jiangsu Nhwa Pharmaceutical Introduction and Business Overview

Table 159. Jiangsu Nhwa Pharmaceutical Risperidone API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 160. Jiangsu Nhwa Pharmaceutical Risperidone API Product Offerings

Table 161. Jiangsu Nhwa Pharmaceutical Recent Development

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Risperidone API Downstream Customers

Table 165. Risperidone API Distributors List

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Risperidone API Product Picture

Figure 2. Global Risperidone API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Risperidone API Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Risperidone API Sales Volume (2020-2031) & (Kg)

Figure 5. Global Risperidone API Sales Price (2020-2031) & (US$/Kg)

Figure 6. Risperidone API Report Years Considered

Figure 7. Global Risperidone API Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Risperidone API Players Sales Volume Ranking (2024) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Risperidone API Revenue in 2024

Figure 10. Risperidone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Above 98 % Picture

Figure 12. Above 99 % Picture

Figure 13. Global Risperidone API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Risperidone API Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Risperidone API Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)

Figure 16. Global Risperidone API Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Risperidone API Price by Type (2020-2031) & (US$/Kg)

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Oral Solution

Figure 20. Product Picture of Capsules

Figure 21. Product Picture of Others

Figure 22. Global Risperidone API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Risperidone API Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Risperidone API Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)

Figure 25. Global Risperidone API Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Risperidone API Price by Application (2020-2031) & (US$/Kg)

Figure 27. North America Risperidone API Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Risperidone API Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Risperidone API Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Risperidone API Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Risperidone API Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Risperidone API Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Risperidone API Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Risperidone API Sales Volume (%), (2020-2031)

Figure 39. United States Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 45. China Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 47. China Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 57. India Risperidone API Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Risperidone API Sales Value by Type (%), 2024 VS 2031

Figure 59. India Risperidone API Sales Value by Application (%), 2024 VS 2031

Figure 60. Risperidone API Industrial Chain

Figure 61. Risperidone API Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Risperidone API market? zhanKai

The top companies in the global Risperidone API market are Interquim SA、Inke S.A、Jai Radhe Sales.

Related Reports

Risperidone API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Risperidone API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 156
USD 3950.00
(Single User License)
Global Risperidone API Market Research Report 2026
The global Risperidone API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 157
USD 2900.00
(Single User License)
Global Risperidone API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Risperidone API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 117
USD 4250.00
(Single User License)
Global Risperidone API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Risperidone API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 198
USD 4900.00
(Single User License)
Global Risperidone API Market Research Report 2025
The global market for Risperidone API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 122
USD 2900.00
(Single User License)
Global Risperidone API Market Research Report 2024
Risperidone(CAS：106266-06-2) is an atypical antipsychotic used to treat schizophrenia and bipolar disorder.
Published Date: 2024-02-07
Pages: 127
USD 2900.00
(Single User License)

Risperidone API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Risperidone API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 156
USD 3950.00 (Single User License)
Global Risperidone API Market Research Report 2026
The global Risperidone API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 157
USD 2900.00 (Single User License)
Global Risperidone API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Risperidone API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 117
USD 4250.00 (Single User License)
Global Risperidone API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Risperidone API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 198
USD 4900.00 (Single User License)
Global Risperidone API Market Research Report 2025
The global market for Risperidone API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 122
USD 2900.00 (Single User License)
Global Risperidone API Market Research Report 2024
Risperidone(CAS：106266-06-2) is an atypical antipsychotic used to treat schizophrenia and bipolar disorder.
Published: 2024-02-07
Pages: 127
USD 2900.00 (Single User License)